Drug-loaded nanoparticles induce immunogenic cell death and efficiently target cells from glioblastoma patients. - Tushe A; Marinelli E; Musca B; Ventura A; Zumerle S; Slukinova O; Zampardi G; Volpin F; Bonaudo C; Della Puppa A; Repellin M; Guerriero G; et al. (Nanomedicine (London, England), 2025)